The Journal of Organic Chemistry
Article
(s, 3H), 1.24 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3)
δ 171.3, 153.6, 151.0, 150.1, 149.8, 148.7, 136.6, 136.4, 133.4, 124.7,
123.1, 62.1, 59.5, 40.0, 39.0, 21.8, 16.1, 14.0; HRMS (ESI): m/z [M +
H]+ calcd for C21H25N2O4 369.1809; found 369.1808.
4,7-Dimethyl-6-(pyrazin-2-yl)-2-tosyl-1,3-dihydropyrrolo[3,4-c]-
pyridine (3br). General procedure A was used with diyne 1b (68.8
mg, 0.25 mmol, 1.0 equiv) and pyrazinecarbonitrile (2r) (26.3 mg,
0.25 mmol, 1.0 equiv). The residue was purified by flash column
chromatography (DCM/ethyl acetate, 1:3) to afford 3br as a white
solid (85.9 mg, 90%); m.p. 189−191 °C; 1H NMR (400 MHz,
CDCl3) δ 9.02 (d, J = 1.5 Hz, 1H), 8.55 (dd, J = 2.6, 1.5 Hz, 1H),
8.51 (d, J = 2.6 Hz, 1H), 7.80−7.73 (m, 2H), 7.31 (d, J = 8.0 Hz,
2H), 4.63 (d, J = 2.3 Hz, 2H), 4.61 (d, J = 2.5 Hz, 2H), 2.41 (s, 3H),
2.38 (s, 3H), 2.29 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ
153.8, 152.1, 149.7, 146.6, 145.9, 144.1, 143.3, 142.7, 133.6, 130.8,
130.0, 127.5, 125.3, 53.5, 52.8, 21.7, 21.6, 15.7; HRMS (ESI): m/z
[M + H]+ calcd for C20H21N4O2S 381.1380; found 381.1380.
Diethyl 1,4-dimethyl-3-(pyridin-4-yl)-5,7-dihydro-cyclopenta[c]-
pyridine-6,6-dicarboxylate (3aq). General procedure A was used
with diyne 1a (66.1 mg, 0.25 mmol, 1.0 equiv) and 4-
pyridinecarbonitrile (2q) (26.0 mg, 0.25 mmol, 1.0 equiv). The
residue was purified by flash column chromatography (hexane/ethyl
acetate, 1:10) to afford 3aq as colorless oil (91.8 mg, 99%); 1H NMR
(400 MHz, CDCl3) δ 8.63−8.59 (m, 2H), 7.37−7.33 (m, 2H), 4.20
(q, J = 7.1 Hz, 4H), 3.58 (s, 2H), 3.55 (s, 2H), 2.43 (s, 3H), 2.16 (s,
3H), 1.24 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ
171.3, 154.0, 151.1, 149.9, 149.7, 148.4, 133.8, 124.4, 124.0, 62.1,
59.4, 40.0, 39.0, 21.8, 15.9, 14.0; HRMS (ESI): m/z [M + H]+ calcd
for C21H25N2O4 369.1809; found 369.1808.
4,7-Dimethyl-6-(pyridin-2-yl)-2-tosyl-1,3-dihydropyrrolo[3,4-c]-
pyridine (3bo). General procedure A was used with diyne 1b (68.8
mg, 0.25 mmol, 1.0 equiv) and 2-pyridinecarbonitrile (2o) (26.0 mg,
0.25 mmol, 1.0 equiv). The residue was purified by flash column
chromatography (hexane/ethyl acetate, 1:10) to afford 3bo as a white
solid (75.6 mg, 80%); m.p. 185−187 °C; 1H NMR (400 MHz,
CDCl3) δ 8.61 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 7.81−7.72 (m, 3H),
7.66 (dt, J = 7.9, 1.1 Hz, 1H), 7.32 (d, J = 8.0 Hz, 2H), 7.25 (ddd, J =
7.5, 4.9, 1.3 Hz, 1H), 4.63 (d, J = 2.2 Hz, 2H), 4.61 (d, J = 2.2 Hz,
2H), 2.41 (s, 3H), 2.39 (s, 3H), 2.25 (s, 3H); 13C{1H} NMR (101
MHz, CDCl3) δ 158.3, 155.5, 149.3, 148.6, 146.3, 144.0, 136.7, 133.6,
130.1, 130.0, 127.5, 124.3, 122.7, 53.6, 52.9, 21.8, 21.6, 15.7; HRMS
(ESI): m/z [M + H]+ calcd for C21H22N3O2S 380.1427; found
380.1425.
Diethyl 1,4-dimethyl-3-(pyrimidin-2-yl)-5,7-dihydro-cyclopenta-
[c]pyridine-6,6-dicarboxylate (3as). To the solution of Cp2Ni (9.4
mg, 0.05 mmol, 20 mol %), Xantphos (57.8 mg, 0.1 mmol, 40 mol %),
and Cs2CO3 (81.5 mg, 0.25 mmol, 1.0 equiv) in toluene (1.0 mL),
diyne 1a (66.1 mg, 0.25 mmol, 1.0 equiv) and pyrimidinecarbonitrile
(2s) (26.3 mg, 0.25 mmol, 1.0 equiv) were added. The reaction
mixture was stirred for 3 h at 80 °C. The residue was purified by flash
column chromatography (DCM/ethyl acetate/methanol, 48:48:4) to
1
afford 3as as pale yellow oil (75.6 mg, 82%); H NMR (400 MHz,
CDCl3) δ 8.83 (d, J = 4.8 Hz, 2H), 7.24 (t, J = 4.9 Hz, 1H), 4.18 (q, J
= 7.1 Hz, 4H), 3.58 (s, 2H), 3.57 (s, 2H), 2.48 (s, 3H), 2.26 (s, 3H),
1.22 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 171.2,
166.3, 157.1, 153.0, 150.9, 150.1, 134.7, 126.1, 119.5, 62.0, 59.6, 39.9,
39.1, 21.9, 15.6, 14.0; HRMS (ESI): m/z [M + H]+ calcd for
C20H24N3O4 370.1761; found 370.1761.
4,7-Dimethyl-6-(pyrimidin-2-yl)-2-tosyl-1,3-dihydropyrrolo[3,4-
c]pyridine (3bs). General procedure A was used with diyne 1b (68.8
mg, 0.25 mmol, 1.0 equiv) and 2-pyrimidinecarbonitrile (2s) (26.3
mg, 0.25 mmol, 1.0 equiv). The residue was purified by flash column
chromatography (DCM/methanol, 96:4) to afford 3bs as a white
solid (64.1 mg, 67%); m.p. 166−168 °C; 1H NMR (400 MHz,
CDCl3) δ 8.84 (d, J = 4.9 Hz, 2H), 7.79−7.73 (m, 2H), 7.31 (d, J =
8.0 Hz, 2H), 7.29−7.26 (m, 1H), 4.63 (d, J = 2.3 Hz, 2H), 4.61 (d, J
= 2.4 Hz, 2H), 2.43 (s, 3H), 2.38 (s, 3H), 2.23 (s, 3H); 13C{1H}
NMR (101 MHz, CDCl3) δ 165.6, 157.2, 153.8, 149.9, 146.4, 144.1,
133.6, 130.9, 130.0, 127.4, 124.9, 119.8, 53.6, 52.9, 21.8, 21.6, 15.6;
HRMS (ESI): m/z [M + H]+ calcd for C20H21N4O2S 381.1380;
found 381.1380.
Tetraethyl 3,3′-(pyridine-2,6-diyl)bis(1,4-dimethyl-5,7-dihydro-
cyclopenta[c]pyridine-6,6-dicarboxylate) (3at). To the solution of
Cp2Ni (9.4 mg, 0.05 mmol, 20 mol %), Xantphos (57.8 mg, 0.1
mmol, 40 mol %), and Cs2CO3 (81.5 mg, 0.25 mmol, 1.0 equiv) in
toluene (1.0 mL), diyne 1a (264.5 mg, 1.0 mmol, 4.0 equiv) and 2,6-
pyridinedicarbonitrile (2t) (32.3 mg, 0.25 mmol, 1.0 equiv) were
added. The reaction mixture was stirred for 3 h at 80 °C. The residue
was purified by flash column chromatography (DCM/ethyl acetate,
1:3) to afford 3at as a white solid (141.9 mg, 86%); m.p. 200−203
°C; 1H NMR (400 MHz, CDCl3) δ 7.86−7.81 (m, 1H), 7.67 (d, J =
7.7 Hz, 2H), 4.19 (q, J = 7.2 Hz, 8H), 3.58 (s, 4H), 3.55 (s, 4H), 2.45
(s, 6H), 2.29 (s, 6H), 1.23 (t, J = 7.1 Hz, 12H); 13C{1H} NMR (101
MHz, CDCl3) δ 171.3, 157.8, 154.8, 150.0, 149.8, 137.2, 133.4, 125.7,
123.0, 61.9, 59.5, 39.9, 39.0, 21.8, 16.0, 14.0; HRMS (ESI): m/z [M +
H]+ calcd for C37H44N3O8 658.3123; found 658.3120.
4,7-Dimethyl-6-(pyridin-3-yl)-2-tosyl-1,3-dihydropyrrolo[3,4-c]-
pyridine (3bp). General procedure A was used with diyne 1b (68.8
mg, 0.25 mmol, 1.0 equiv) and 3-pyridinecarbonitrile (2p) (26.0 mg,
0.25 mmol, 1.0 equiv). The residue was purified by flash column
chromatography (DCM/ethyl acetate/methanol, 48:48:4) to afford
1
3bp as a brown solid (87.1 mg, 92%); m.p. 133−135 °C; H NMR
(400 MHz, CDCl3) δ 8.67 (s, 1H), 8.60 (d, J = 3.9 Hz, 1H), 7.84−
7.72 (m, 3H), 7.41−7.30 (m, 3H), 4.64 (d, J = 2.2 Hz, 2H), 4.61 (d, J
= 2.2 Hz, 2H), 2.41 (d, J = 2.0 Hz, 6H), 2.15 (s, 3H); 13C{1H} NMR
(101 MHz, CDCl3) δ 154.6, 150.1, 150.0, 149.1, 146.2, 144.1, 136.7,
135.7, 133.7, 130.1, 130.0, 127.6, 123.5, 123.3, 53.5, 52.8, 21.8, 21.7,
16.0; HRMS (ESI): m/z [M + H]+ calcd for C21H22N3O2S 380.1427;
found 380.1424.
4,7-Dimethyl-6-(pyridin-4-yl)-2-tosyl-1,3-dihydropyrrolo[3,4-c]-
pyridine (3bq). General procedure A was used with diyne 1b (68.8
mg, 0.25 mmol, 1.0 equiv) and 4-pyridinecarbonitrile (2q) (26.0 mg,
0.25 mmol, 1.0 equiv). The residue was purified by flash column
chromatography (DCM/ethyl acetate/methanol, 48:48:4) to afford
1
3bq as a yellow solid (83.1 mg, 88%); m.p. 128−130 °C; H NMR
(400 MHz, CDCl3) δ 8.68 (d, J = 5.8 Hz, 2H), 7.87−7.73 (m, 2H),
7.43−7.30 (m, 4H), 4.65 (d, J = 2.2 Hz, 2H), 4.63 (d, J = 2.3 Hz,
2H), 2.43 (s, 6H), 2.16 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ
154.9, 150.1, 149.8, 147.6, 146.2, 144.1, 133.6, 130.3, 130.1, 127.6,
123.9, 123.2, 53.5, 52.7, 21.8, 21.6, 15.8; HRMS (ESI): m/z [M +
H]+ calcd for C21H22N3O2S 380.1427; found 380.1426.
Diethyl 1,4-dimethyl-3-(pyrazin-2-yl)-5,7-dihydro-cyclopenta[c]-
pyridine-6,6-dicarboxylate (3ar). To the solution of Cp2Ni (9.4 mg,
0.05 mmol, 20 mol %), Xantphos (57.8 mg, 0.1 mmol, 40 mol %), and
Cs2CO3 (81.5 mg, 0.25 mmol, 1.0 equiv) in toluene (1.0 mL), diyne
1a (66.1 mg, 0.25 mmol, 1.0 equiv) and pyrazinecarbonitrile (2r)
(26.3 mg, 0.25 mmol, 1.0 equiv) were added. The reaction mixture
was stirred for 3 h at 80 °C. The residue was purified by flash column
chromatography (DCM/ethyl acetate, 1:1) to afford 3ar as a white
solid (79.4 mg, 86%); m.p. 84−87 °C; 1H NMR (400 MHz, CDCl3)
δ 9.00 (d, J = 1.5 Hz, 1H), 8.55 (dd, J = 2.6, 1.5 Hz, 1H), 8.49 (d, J =
2.6 Hz, 1H), 4.20 (q, J = 7.1 Hz, 4H), 3.59 (s, 2H), 3.58 (s, 2H), 2.46
(s, 3H), 2.32 (s, 3H), 1.24 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (101
MHz, CDCl3) δ 171.2, 154.5, 151.5, 150.9, 150.3, 146.0, 143.0, 142.8,
134.5, 126.5, 62.1, 59.5, 39.9, 39.1, 21.8, 15.7, 14.1; HRMS (ESI): m/
z [M + H]+ calcd for C20H24N3O4 370.1761; found 370.1761.
Diethyl 4-methyl-3-phenyl-5,7-dihydro-cyclopenta[c]pyridine-
6,6-dicarboxylate (4ea). General procedure C was used with diyne
1e (187.7 mg, 0.75 mmol, 1.0 equiv) and benzonitrile (2a) (193.4
mg, 1.88 mmol, 2.5 equiv). The residue was purified by flash column
chromatography (hexane/ethyl acetate, 6:1) to afford 4ea as yellow
1
oil (102.8 mg, 39%); H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H),
7.48−7.31 (m, 5H), 4.23 (q, J = 7.1 Hz, 4H), 3.68 (s, 2H), 3.58 (s,
2H), 2.24 (s, 3H), 1.27 (t, J = 7.1 Hz, 6H); 13C{1H} NMR (101
MHz, CDCl3) δ 171.3, 157.2, 149.9, 142.3, 140.5, 134.5, 129.1, 128.1,
127.8, 126.9, 62.1, 60.0, 39.8, 38.6, 16.5, 14.1; HRMS (ESI): m/z [M
+ H]+ calcd for C21H24NO4 354.1700; found 354.1697.
Diethyl 4-methyl-3-(pyridin-2-yl)-5,7-dihydro-cyclopenta[c]-
pyridine-6,6-dicarboxylate (4eo). General procedure C was used
with diyne 1e (187.7 mg, 0.75 mmol, 1.0 equiv) and 2-
9339
J. Org. Chem. 2021, 86, 9328−9343